Coherus BioSciences, Inc. (CHRS) financial statements (2021 and earlier)

Company profile

Business Address C/O DENNIS M. LANFEAR
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:54117872127125158150
Cash and cash equivalents54117872127125158150
Other undisclosed cash, cash equivalents, and short-term investments0      
Restricted cash and investments  00000
Receivables157142 1224
Inventory, net of allowances, customer advances and progress billings44102    
Inventory44102    
Prepaid expense  218323520
Other current assets  00332
Other undisclosed current assets25148(1)  2
Total current assets:76734384145161197179
Noncurrent Assets
Inventory, Noncurrent48454    
Finance lease, right-of-use asset1 
Operating lease, right-of-use asset1011
Property, plant and equipment 671311114
Intangible assets, net (including goodwill)4444444
Goodwill1111111
Intangible assets, net (excluding goodwill)3333333
Restricted cash and investments001111 
Other noncurrent assets2000200
Other undisclosed noncurrent assets9      
Total noncurrent assets:7466151717158
TOTAL ASSETS:84240999163178212187
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities60623325485023
Accounts payable1526151520269
Accrued liabilities231779282411
Employee-related liabilities221811   3
Debt12     
Due to related parties      2
Business combination, contingent consideration, liability   3616
Deferred revenue and credits 15023
Other liabilities4200000
Other undisclosed current liabilities8149 025(2)
Total current liabilities:14611533285610652
Noncurrent Liabilities
Long-term debt and lease obligation387162777675  
Long-term debt, excluding current maturities377152777675  
Finance lease, liability1 
Operating lease, liability910
Liabilities, other than long-term debt28262727284741
Deferred revenue and credits 14540
Due to related parties2726262525  
Other liabilities1 22220
Business combination, contingent consideration, liability000   1
Other undisclosed noncurrent liabilities     6628
Total noncurrent liabilities:41518910510410311369
Total liabilities:561304138132159219120
Stockholders' equity
Stockholders' equity attributable to parent281105(39)3221(6)67
Common stock0000000
Additional paid in capital1,0441,001947808558404254
Accumulated other comprehensive loss(0)(1)(0)(1)(1)(0)(1)
Accumulated deficit(763)(895)(985)(775)(537)(410)(187)
Stockholders' equity attributable to noncontrolling interest   (1)(1)(1)(0)
Total stockholders' equity:281105(39)3119(7)67
TOTAL LIABILITIES AND EQUITY:84240999163178212187

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues476356 21903031
Revenue, net21903031
Cost of revenue
(Cost of Goods and Services Sold)
(38)(0)     
Gross profit:438356 21903031
Operating expenses(282)(248)(204)(234)(306)(249)(96)
Other undisclosed operating income 0     
Operating income (loss):156108(204)(232)(116)(219)(65)
Nonoperating income (expense)1353(4)(5)(18)
Investment income, nonoperating1      
Foreign currency transaction gain (loss), before tax(0)0    1
Other nonoperating income (expense)1353(4)(5)(19)
Interest and debt expense(21)(18)(10)(10)(8)(0)(2)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)(0)     
Income (loss) from continuing operations before equity method investments, income taxes:13693(209)(238)(128)(224)(84)
Other undisclosed income from continuing operations before income taxes 0     
Income (loss) from continuing operations before income taxes:13693(209)(238)(128)(224)(84)
Income tax expense(3)(3)     
Income (loss) before gain (loss) on sale of properties:13290(209)(238)(128)(224)(84)
Other undisclosed net loss      (3)
Net income (loss):13290(209)(238)(128)(224)(87)
Net income attributable to noncontrolling interest  00010
Net income (loss) available to common stockholders, diluted:13290(209)(238)(127)(223)(87)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):13290(209)(238)(128)(224)(87)
Other undisclosed comprehensive income (loss)0(0)0(0)(0)0(1)
Comprehensive income (loss):13390(209)(238)(128)(224)(88)
Comprehensive income, net of tax, attributable to noncontrolling interest  00010
Comprehensive income (loss), net of tax, attributable to parent:13390(209)(238)(128)(223)(88)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: